- 基本信息
导师姓名:
|
沈赞
|
学科代码:
|
100214
|
|
性别:
|
男
|
学科名称:
|
肿瘤学
|
培养单位:
|
附属第六人民医院
|
三级学科
|
|
导师类型:
|
博士生导师
|
专业领域名称:
|
肿瘤学 专业学位
|
联系方式:
|
|
专业领域代码:
|
105121
|
邮编:
|
200233
|
邮箱地址:
|
sshenzzan@vip.sina.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
中国乳腺癌专业委员会青年委员
|
中华医学会肿瘤分会委员兼姑息治疗学组组长
|
上海医学会肿瘤分会副主任委员
|
中国医药教育协会疑难肿瘤专委会主任委员
|
- 科研项目
81972521 | DGKZ-ERK1/2-MYC信号通路在促进骨肉瘤复发转移中的作用机制研究 | 国家自然科学基金委 |
2020-01~2023-12
|
55万元
| 课题负责人 |
81672658 | vastatin/JAG2/Pck1信号通路在骨肉瘤转移中的抑制作用及其机制研究 | 国家自然科学基金面上项目 |
2017-01~2019-12
|
53万元
| 课题负责人 |
2016YFC0106204 | 肿瘤局部消融激发全身免疫应答疗效分析及循证评价 | 科技部 |
2016-07~2019-06
|
143万元
| 课题负责人 |
81172105 | SKA1 基因在骨肉瘤原发耐药中的作用机制研究 | 国家自然科学基金面上项目 |
2012-01~2015-12
|
60万元
| 课题负责人 |
30872991 | AAV-HGFK1联合Adv-p53在抑制乳腺癌骨转移中的作用机制研究 | 国家自然基金委,面上项目 |
2009-01~2011-12
|
31万元
| 课题负责人 |
08PJ1407300 | AAV-HGFK1联合Adv-p53对于前列腺癌骨转移的作用机制研究 | 上海市科委 |
2008-08~2010-08
|
20万元
| 课题负责人 |
- 学术论文
YUAN YUAN, YONGGANG WANG, ZIMEI LIU, YONG SUN, YANG YAO, WENXI YU and ZAN SHEN
|
MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen
|
INTERNATIONAL JOURNAL OF ONCOLOGY
|
2019
|
Jun;54(6):2019-2029
|
Wenxi Yua, Lina Tanga, Feng Lina, Lixin Jiangb,,
|
Significance of HIFU in local unresectable recurrence of soft tissue sarcoma,a single-center, respective, case series in China
|
Surgical Oncology
|
2019
|
(2019) 117–121
|
Wenxi Yu, Daliu Min, Feng Lin, Shuier Zheng, Lina Tang, Aina He, Haiyan Hu and Zan Shen
|
SKA1 induces de novo MTX-resistance in osteosarcoma through inhibiting FPGS transcription
|
Febs Journal
|
2019
|
286(12):2399-2414
|
L. Tang · W. Yu · Y. Wang · H. Li · Z. Shen
|
Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma
|
Clin Transl Oncol.
|
2019
|
2019 Apr 8.
|
Zhang JJ, Zhou Y, Hu HY Sun YJ, Wang YG, Gu YF, Wu CG, Shen Z,
|
Safety and efficacy of multilevel vertebroplasty for painful osteolytic spinal metastases: a single-centre experience.
|
Eur Radiol
|
2017
|
Aug;27(8):3436-3442
|
Sun Z,Yue L,, Li Y, Sui A, Li T, Tang Q, Yao R, Sun Y
|
Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin.
|
Downregulation of NPM expression by Her-2 reduces resistance of gastric cancer to oxaliplatin.
|
2017
|
2017 Apr;13(4):2377-2384
|
Gan Z, Lin S, Han K,, Yao Y, Min D.
|
Bilateral spontaneous pneumothorax in an osteosarcoma patient with pulmonary metastases: A case report.
|
Oncol Lett.
|
2016
|
2016 Feb;11(2):1179-1180.
|
, Yao C, Wang Z, Yue L, Fang Z, Kung HF, Lin MC
|
Vastatin is an endogenous antiangiogenes is polypeptide that is lost in HCC, effectively inhibits tumor metastasis
|
Molecular Therapy
|
2016
|
24(8): 1358-1368.
|
Yu Wen xi, Tang Lina, Lin Feng, Yao Yang,
|
Accuracy of Tokuhashi score system in predicting survival of lung cancer patients with vertebral metastasis.
|
J Neuro-oncol.
|
2015
|
125(2):427-33.
|
Yu W, Zhang Z, Min D, Yang Q, Du X, Tang L, Lin F, Sun Y, Zhao H, Zheng S, He A, Li H, Yao Y,
|
Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
|
Eur J Cancer.
|
2014
|
50(6):1125-36.
|
Yu W,Tang L,Lin F, Li D, Wang J, Yang Y,
|
Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma.
|
Int J Oncol.
|
2014
|
44(4):1091-8.
|
Yao Y, Fang ZP, Chen H, Yue L, Min DL, Tang LN, Yu WX, Kung HF, Lin MC,
|
HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway
|
Cancer Gene Ther.
|
|
19(9):601-608
|
Li H, Min D, Zhao H, Wang Z, Qi W, Zheng S, Tang L, He A, Sun Y, Yao Y,, Min D, Zhao H, Wang Z, Qi W, Zheng S, Tang L, He A, Sun Y, Yao Y, Shen Z.
|
The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
|
PLoS One
|
|
8(6):64513-64513
|
|